Page last updated: 2024-08-26

nicotine and 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide

nicotine has been researched along with 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mahapatra, NR; Mahata, M; Mahata, SK; O'Connor, DT	1

Other Studies

1 other study(ies) available for nicotine and 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide

Article	Year
Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells. Molecular pharmacology, 2002, Volume: 61, Issue:6 Topics: Animals; Binding, Competitive; Catecholamines; Chromaffin Cells; Enzyme Activation; Enzyme Inhibitors; Indoles; Maleimides; Nicotine; Nicotinic Antagonists; PC12 Cells; Pheochromocytoma; Protein Kinase C; Rats; Receptors, Nicotinic	2002

Article

Year

Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells.

Molecular pharmacology, 2002, Volume: 61, Issue:6

Topics: Animals; Binding, Competitive; Catecholamines; Chromaffin Cells; Enzyme Activation; Enzyme Inhibitors; Indoles; Maleimides; Nicotine; Nicotinic Antagonists; PC12 Cells; Pheochromocytoma; Protein Kinase C; Rats; Receptors, Nicotinic

2002